Drug reference
Ethinylestradiol, Etonogestrel
Progestogen · Contraception
Also known as NuvaRing, SyreniRing
ProgestogenContraception
CDSCO approvedSchedule H
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Combination hormonal contraceptives prevent ovulation by suppressing LH and FSH levels, thereby inhibiting the mid-cycle LH surge and diminishing endogenous steroid levels. This synergistic action of estrogen and progestin consistently suppresses ovulation. Progestin also plays a major role by diminishing the frequency of GnRH pulses, which are essential for LH pulse frequency and ovulation.
Indications
Contraception
Dosing
- Adult
- Insert one vaginal ring and leave in place for 3 consecutive weeks, followed by a 7-day ring-free interval. A new ring is inserted after this 7-day interval. If the ring is expelled for more than 3 hours during week 1 or 2, rinse and reinsert; use additional barrier precautions for 7 days.…
Pharmacokinetics
Onset
Full contraceptive protection may take 7 days if initiated later than day 5 of the menstrual cycle, or after re-insertion following an extended ring-free interval or expulsion.
Duration
The ring is used for 3 weeks, providing continuous hormone release. Contraceptive protection can extend up to 4 weeks of continuous use.
Other Progestogen drugs
Ask House about Ethinylestradiol, Etonogestrel
Continue into a citation-backed clinical answer with the drug context already attached.